About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/25/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/25/2021.

Perioperative Continuous Glucose Monitoring in Patients Undergoing an Abdominal Surgery

Clinicaltrials.gov identifier NCT03935919

Recruitment Status Completed

First Posted May 2, 2019

Last update posted April 8, 2020

Study Description

Brief summary:

The purpose of this study it to assess whether the continuous glucose monitor system Dexcom G6® can be reliably used for perioperative glucose monitoring in 20 prediabetic or diabetic patients undergoing abdominal surgery in terms of data continuity, accuracy and patient tolerability.

  • Condition or Disease:Diabetes Mellitus
    Prediabetes
  • Intervention/Treatment:
  • Phase: N/A
Detailed Description

The current recommended method for monitoring glucose control is bedside point of care capillary blood glucose testing. A significant limitation for this method is the frequency by which blood glucose testing is typically performed, at most 4-6 times daily. Continuous glucose monitoring (CGM) provides an alternative approach to measure glucose values with the advantage of greater frequency of monitoring as it is measured every few minutes. Whilst CGM use in the outpatient setting is rising and has demonstrated benefits on glycaemic control, the accuracy of these devices perioperatively is less investigated. In this study the sixth-generation factory-calibrated real-time Dexcom G6® system will be used as a CGM and its glucose values perioperatively will be compared to the capillary glucose values which will be measured simultaneously by the Accu-Check Inform II (Roche Diagnostics) point-of-care blood glucose meter. The Investigators aim to assess the feasibility and accuracy of perioperative CGM.

Study Design
  • Study Type: Observational [Patient Registry]
  • Actual Enrollment: 20 participants
  • Observational Model: Cohort
  • Time Perspective: Prospective
  • Official Title: Perioperative Continuous Glucose Monitoring in Patients Undergoing an Abdominal Surgery — an Observational Study
  • Actual Study Start Date: August 2019
  • Actual Primary Completion Date: February 2020
  • Actual Study Completion Date: March 2020
Outcome Measures
  • Primary Outcome Measures: 1. Sensor accuracy in the perioperative period [ Time Frame: 1 day ]
    Mean Absolute Relative Difference (MARD) between Dexcom G6 sensor glucose values and capillary blood glucose values measured using the Accu-Check Inform II meter in the perioperative period (%)
  • Secondary Outcome Measures: 1. Median absolute relative difference between sensor glucose and reference glucose in the preoperative period (%) [ Time Frame: 1 week ]
    Median absolute relative difference between sensor glucose and reference glucose (for reference values >3.9 and <10.0mmol/l, for reference values ≤3.9mmol/l, for reference values ≥10.0mmol/l) in the preoperative period (%)
  • 2. Mean absolute relative difference between sensor glucose and reference glucose in the preoperative period (%) [ Time Frame: 1 week ]
    Mean absolute relative difference between sensor glucose and reference glucose (for reference values >3.9 and <10.0mmol/l, for reference values ≤3.9mmol/l, for reference values ≥10.0mmol/l) in the preoperative period (%)
  • 3. Mean absolute relative difference between sensor glucose and reference glucose in the postoperative period (%) [ Time Frame: 1-2 weeks ]
    Mean absolute relative difference between sensor glucose and reference glucose (for reference values >3.9 and <10.0mmol/l, for reference values ≤3.9mmol/l, for reference values ≥10.0mmol/l) in the postoperative period (%)
  • 4. Mean sensor glucose value in the perioperative period [ Time Frame: 1 day ]
    Mean value of the sensor glucose levels in the perioperative period
  • 5. Median absolute relative difference between sensor glucose and reference glucose in the perioperative period (%) [ Time Frame: 1 day ]
    Median absolute relative difference between sensor glucose and reference glucose (for reference values >3.9 and <10.0mmol/l, for reference values ≤3.9mmol/l, for reference values ≥10.0mmol/l) in the perioperative period (%)
  • 6. Median absolute relative difference between sensor glucose and reference glucose in the postoperative period (%) [ Time Frame: 1-2 weeks ]
    Median absolute relative difference between sensor glucose and reference glucose (for reference values >3.9 and <10.0mmol/l, for reference values ≤3.9mmol/l, for reference values ≥10.0mmol/l) in the postoperative period (%)
  • 7. Percentage of sensor measurements in the preoperative period within the limits specified by the International Organization of Standardization (ISO) : 15197:2013 criteria [ Time Frame: 1 week ]
    Proportion of sensor measurements in the preoperative period within ±15% of reference glucose if the reference value is ≥5.6mmol/l and within 0.8mmol/l if the reference values is <5.6mmol/l (%)
  • 8. Percentage of sensor measurements in the perioperative period within the limits specified by the ISO: 15197:2013 criteria [ Time Frame: 1 day ]
    Proportion of sensor measurements in the perioperative period within ±15% of reference glucose if the reference value is ≥5.6mmol/l and within 0.8mmol/l if the reference values is <5.6mmol/l (%)
  • 9. Percentage of sensor measurements in the postoperative period within the limits specified by the ISO: 15197:2013 criteria [ Time Frame: 1-2 weeks ]
    Proportion of sensor measurements in the postoperative period within ±15% of reference glucose if the reference value is ≥5.6mmol/l and within 0.8mmol/l if the reference values is <5.6mmol/l (%)
  • 10. Bias and 95% limits of agreement of sensor glucose compared to reference glucose in the preoperative period [ Time Frame: 1 week ]
    Calculation of bias and 95% limits of agreement of sensor glucose compared to reference glucose in the preoperative period
  • 11. Bias and 95% limits of agreement of sensor glucose compared to reference glucose in the perioperative period [ Time Frame: 1 day ]
    Calculation of bias and 95% limits of agreement of sensor glucose compared to reference glucose in the perioperative period
  • 12. Bias and 95% limits of agreement of sensor glucose compared to reference glucose in the postoperative period [ Time Frame: 1-2 weeks ]
    Calculation of bias and 95% limits of agreement of sensor glucose compared to reference glucose in the postoperative period
  • 13. Clarke error grid analysis in the preoperative period [ Time Frame: 1 week ]
    Proportion of sensor glucose values in Clark's error grid zones (A, B, A+B, C, D, E)in the preoperative period (%)
  • 14. Clarke error grid analysis in the perioperative period [ Time Frame: 1 day ]
    Proportion of sensor glucose values in Clark's error grid zones (A, B, A+B, C, D, E) in the perioperative period (%)
  • 15. Clarke error grid analysis in the postoperative period [ Time Frame: 1-2 weeks ]
    Proportion of sensor glucose values in Clark's error grid zones (A, B, A+B, C, D, E) in the postoperative period (%)
  • 16. Sensor availability in the preoperative period (%) [ Time Frame: 1 week ]
    Proportion of study period with available sensor glucose values in the preoperative period
  • 17. Sensor availability in the perioperative period (%) [ Time Frame: 1 day ]
    Proportion of study period with available sensor glucose values in the perioperative period
  • 18. Sensor availability in the postoperative period (%) [ Time Frame: 1-2 weeks ]
    Proportion of study period with available sensor glucose values in the postoperative period
  • 19. Number of sensor replacement events in the preoperative period [ Time Frame: 1 week ]
    Number of times that the sensor needed to be replaced in the preoperative period
  • 20. Number of sensor replacement events in the perioperative period [ Time Frame: 1 day ]
    Number of times that the sensor needed to be replaced in the perioperative period
  • 21. Number of sensor replacement events in the postoperative period [ Time Frame: 1-2 weeks ]
    Number of times that the sensor needed to be replaced in the postoperative period
  • 22. Number of adverse device effects in the preoperative period [ Time Frame: 1 week ]
    Adverse event related to the use of study devices (e.g. skin irritative and allergic reactions, bleeding) in the preoperative period
  • 23. Number of adverse device effects in the perioperative period [ Time Frame: 1 day ]
    Adverse event related to the use of study devices (e.g. skin irritative and allergic reactions, bleeding) in the perioperative period
  • 24. Number of adverse device effects in the postoperative period [ Time Frame: 1-2 weeks ]
    Adverse event related to the use of study devices (e.g. skin irritative and allergic reactions, bleeding) in the postoperative period
  • 25. Percentage of time in the preoperative period with sensor glucose levels within target range [ Time Frame: 1 week ]
    Proportion of time in the preoperative period with sensor glucose levels between 3.9-10.0mmol/l
  • 26. Percentage of time in the perioperative period with sensor glucose levels within target range [ Time Frame: 1 day ]
    Proportion of time in the perioperative period with sensor glucose levels between 3.9-10.0mmol/l
  • 27. Percentage of time in the postoperative period with sensor glucose levels within target range [ Time Frame: 1-2 weeks ]
    Proportion of time in the postoperative period with sensor glucose levels between 3.9-10.0mmol/l
  • 28. Percentage of time in the preoperative period with sensor glucose levels below target range [ Time Frame: 1 week ]
    Proportion of time in the preoperative period with sensor glucose levels below 3.9mmol/l
  • 29. Percentage of time in the perioperative period with sensor glucose levels below target range [ Time Frame: 1 day ]
    Proportion of time in the perioperative period with sensor glucose levels below 3.9mmol/l
  • 30. Percentage of time in the postoperative period with sensor glucose levels below target range [ Time Frame: 1-2 weeks ]
    Proportion of time in the postoperative period with sensor glucose levels below 3.9mmol/l
  • 31. Percentage of time in the preoperative period with sensor glucose levels above target range [ Time Frame: 1 week ]
    Proportion of time in the preoperative period with sensor glucose levels above 10.0mmol/l
  • 32. Percentage of time in the perioperative period with sensor glucose levels above target range [ Time Frame: 1 day ]
    Proportion of time in the perioperative period with sensor glucose levels above 10.0mmol/l
  • 33. Percentage of time in the postoperative period with sensor glucose levels above target range [ Time Frame: 1-2 weeks ]
    Proportion of time in the postoperative period with sensor glucose levels above 10.0mmol/l
  • 34. Mean sensor glucose value in the preoperative period [ Time Frame: 1 week ]
    Mean value of the sensor glucose levels in the preoperative period
  • 35. Mean sensor glucose value in the postoperative period [ Time Frame: 1-2 weeks ]
    Mean value of the sensor glucose levels in the postoperative period
  • 36. Standard deviation of sensor glucose levels in the preoperative period [ Time Frame: 1 week ]
    Standard Deviation of the sensor glucose levels in the preoperative period
  • 37. Standard deviation of sensor glucose levels in the perioperative period [ Time Frame: 1 day ]
    Standard Deviation of the sensor glucose levels in the perioperative period
  • 38. Standard deviation of sensor glucose levels in the postoperative period [ Time Frame: 1-2 weeks ]
    Standard Deviation of the sensor glucose levels in the postoperative period
Eligibility Criteria
  • Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
  • Sampling Method: Probability Sample
  • Study Population: The study will involve a total of 20 adults with pre-diabetes, type 1 or type 2 diabetes who will undergo elective abdominal surgery at the University Hospital Bern.
Criteria

Inclusion criteria:

- Aged ≥18 years

- Pre-diabetic (HbA1c 5.7-6.5%) or diabetic (regardless of aetiology)

- Scheduled to have elective abdominal surgery at the University Hospital Bern

- Surgery duration >2 hours

Exclusion criteria:

- Planned MRI procedure during hospitalization

- Inability to follow procedures

- Incapacity to give informed consent

- Presence of extensive skin abnormalities at the sensor insertion site (upper arm)

- Known allergic/irritative skin reactions to dressings/adhesives

- Haematocrit values outside the normal range

- Patients with immunosuppression defined as neutrophil count <0.5x10^9/L - Patients on isolation precautions (contact, droplet, airborne) - Pregnancy or breast-feeding

Contacts and Locations
Contacts
Locations

Switzerland
Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital
Bern

Sponsors and Collaborators

University Hospital Inselspital, Berne

Investigators

Principal Investigator: Lia Bally, MD PhD Inselspital, University Hospital of Bern, University of Bern

More Information
  • Responsible Party: University Hospital Inselspital, Berne
  • ClinicalTrials.gov Identifier: NCT03935919 History of Changes
  • Other Study ID Numbers: GluPop
  • First Posted: May 2, 2019 Key Record Dates
  • Last Update Posted: April 8, 2020
  • Last Verified: April 2020
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by University Hospital Inselspital, Berne: perioperative glucose management
    continuous glucose monitoring
    diabetes
  • Additional relevant MeSH terms: Prediabetic State